HealthMore in Health→
Anthropic’s Board Pick Signals a Deeper Push Into Biopharma
Key Takeaways
- Endpoints says Anthropic has appointed Novartis CEO Vas Narasimhan to its board.
- The article frames the move as part of Anthropic’s deepening ties to biopharma.
- A recent acquisition of Coefficient Bio reinforces that strategic direction.
DE
DT Editorial Team··via endpoints.news